Status:
COMPLETED
Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) Care
Lead Sponsor:
Boston Children's Hospital
Conditions:
Intrauterine Growth Retardation
Prematurity
Eligibility:
All Genders
Up to 36 years
Phase:
NA
Brief Summary
The purpose of the study is to learn more about the development of small for gestational age (SGA) preterm infants and whether focusing on the infant's behavior has a positive effect on outcome. The s...
Detailed Description
The preterm infant who is not only born early but also did not grow well in the womb is at double jeopardy for developmental disabilities. The literature indicates that the fetus who has not gained we...
Eligibility Criteria
Inclusion
- Inborn at the Brigham and Women's Hospital
- Gestational age \< 36 weeks
- Birthweight \< 5th percentile
- Head circumference at birth \< 5th percentile
Exclusion
- Presence of major chromosomal or congenital anomalies (Down's, Turner's, Klinefelter's Syndrome, etc.)
- Presence of major congenital infections (HIV, TORCH)
- Presence of significant prenatal focal brain lesions (intrauterine infarcts; cystic changes, etc.)
- Presence of major maternal illness (uncontrolled diabetes, active seizure disorder requiring medication during pregnancy, renal transplant), mental and/or emotional impairment (including heroin addiction and documented alcoholism)
Key Trial Info
Start Date :
October 1 1996
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2002
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00914108
Start Date
October 1 1996
End Date
July 1 2002
Last Update
June 4 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
2
Children's Hospital Boston
Boston, Massachusetts, United States, 02115